Avestar Capital, LLC Bristol Myers Squibb CO Transaction History

Avestar Capital, LLC

$951 Million
Q3 2024

A detailed history of Avestar Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Avestar Capital, LLC holds 11,315 shares of BMY stock, worth $666,114. This represents 0.06% of its overall portfolio holdings.

Number of Shares

11,315

Previous 7,022 61.14%

Holding current value

$666,114

Previous $291,000 101.03%

% of portfolio

0.06%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $170,260 - $222,162	4,293 Added 61.14%	11,315 $585,000
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $123,366 - $162,414	-3,065 Reduced 30.39%	7,022 $291,000
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $200,748 - $227,609	4,184 Added 70.88%	10,087 $547,000
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $9,550 - $11,396	197 Added 3.45%	5,903 $302,000
Q3 2023 Oct 20, 2023	BUY	$57.89 - $64.73 $99,512 - $111,270	1,719 Added 43.12%	5,706 $331,000
Q2 2023 Aug 01, 2023	SELL	$63.71 - $70.74 $50,649 - $56,238	-795 Reduced 16.62%	3,987 $254,000
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $328 - $372	5 Added 0.1%	4,782 $331,000
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $54,099 - $64,061	790 Added 19.81%	4,777 $0
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $125 - $74,227	-966 Reduced 19.5%	3,987 $283,000
Q2 2022 Jul 28, 2022	SELL	$72.62 - $79.98 $74,362 - $81,899	-1,024 Reduced 17.13%	4,953 $381,000
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $345,579 - $414,380	-5,621 Reduced 48.47%	5,977 $437,000
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $316,792 - $369,305	5,907 Added 103.8%	11,598 $723,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $2.39 Million - $2.8 Million	-40,338 Reduced 87.64%	5,691 $337,000
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $549,575 - $598,487	8,877 Added 23.89%	46,029 $3.08 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $1.84 Million - $2.07 Million	31,053 Added 509.15%	37,152 $2.45 Million
Q4 2020 Feb 01, 2021	BUY	$57.74 - $65.43 $352,156 - $399,057	6,099 New	6,099 $378,000
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $66,721 - $79,107	-1,560 Closed	0 $0
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $7,094 - $7,845	159 Added 11.35%	1,560 $64,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $2,346 - $2,797	-52 Reduced 3.58%	1,401 $63,000
Q4 2018 Jan 25, 2019	BUY	$48.76 - $63.23 $1,755 - $2,276	36 Added 2.54%	1,453 $72,000
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $2,317 - $2,614	-42 Reduced 2.88%	1,417 $84,000
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $5,962 - $7,431	118 Added 8.8%	1,459 $77,000
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $4,613 - $5,311	77 Added 6.09%	1,341 $82,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $75,764 - $82,602	1,264	1,264 $75,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Bristol Myers Squibb CO Transaction History